An overview of epithelial growth factor receptor (EGFR) inhibitors in cancer therapy

KS Alharbi, MAJ Shaikh, O Afzal, ASA Altamimi… - Chemico-Biological …, 2022 - Elsevier
Epithelial growth factor receptor (EGFR), a transmembrane receptor on the cell surface,
carries extracellular messages into the cell and alters the activity of the nucleus through …

Altered glycosylation in cancer: molecular functions and therapeutic potential

X Xu, Q Peng, X Jiang, S Tan, W Yang… - Cancer …, 2024 - Wiley Online Library
Glycosylation, a key mode of protein modification in living organisms, is critical in regulating
various biological functions by influencing protein folding, transportation, and localization …

[HTML][HTML] Insights into the role of glycosyltransferase in the targeted treatment of gastric cancer

Y Wang, P Zhang, Z Luo, C Huang - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Gastric cancer is a remarkably heterogeneous tumor. Despite some advances in the
diagnosis and treatment of gastric cancer in recent years, the precise treatment and curative …

Capacitive nanobiosensing of β-1, 4-galactosyltransferase-V colorectal cancer biomarker

D Echeverri, AF Cruz-Pacheco, J Orozco - Sensors and Actuators B …, 2023 - Elsevier
Abstract β-1, 4-GalT-V is an enzyme with glycosyltransferase activity that glycosylates
proteins and synthesizes the lactosylceramide sphingolipid in the Golgi apparatus …

Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine

Y Guo, W Jia, J Yang, X Zhan - Frontiers in endocrinology, 2022 - frontiersin.org
Glycosylation is one of the most important post-translational modifications (PTMs) in a
protein, and is the most abundant and diverse biopolymer in nature. Glycans are involved in …

Serum IgG N‐glycans enable early detection and early relapse prediction of colorectal cancer

Y Gu, B Duan, J Sha, R Zhang, J Fan… - … Journal of Cancer, 2023 - Wiley Online Library
Colorectal cancer (CRC) develops mainly from colorectal advanced adenomas (AA), which
are considered precancerous lesions. Novel early diagnostic biomarkers are urgently …

β-1, 4-Galactosyltransferase-V colorectal cancer biomarker immunosensor with label-free electrochemical detection

D Echeverri, J Orozco - Talanta, 2022 - Elsevier
Abstract β-1, 4-Galactosyltransferase-V (β-1, 4-GalT-V) is a membrane-bound glycoprotein
with glycosyltransferase enzyme activity that synthesizes lactosylceramide and glycosylates …

Targeting protein glycosylation to regulate inflammation in the respiratory tract: novel diagnostic and therapeutic candidates for chronic respiratory diseases

X Xie, S Kong, W Cao - Frontiers in Immunology, 2023 - frontiersin.org
Protein glycosylation is a widespread posttranslational modification that can impact the
function of proteins. Dysregulated protein glycosylation has been linked to several diseases …

A protein microarray‐based serum proteomic investigation reveals distinct autoantibody signature in colorectal cancer

A Barpanda, C Tuckley, A Ray… - PROTEOMICS …, 2023 - Wiley Online Library
Purpose Colorectal cancer (CRC) has been reported as the second leading cause of cancer
death worldwide. The 5‐year annual survival is around 50%, mainly due to late diagnosis …

FUT2 promotes colorectal cancer metastasis by reprogramming fatty acid metabolism via YAP/TAZ signaling and SREBP-1

C Dong, Y Zhang, J Zeng, S Chong, Y Liu… - Communications …, 2024 - nature.com
Colorectal cancer (CRC) ranks as the second most lethal cancer worldwide because of its
high rate of metastasis, and approximately 20% of CRC patients have metastases at initial …